leadf
logo-loader
CSE:HUGE NASDAQ:HUGE

FSD Pharma

Receive alerts
Market:
CSE
Market Cap:
$50.4 m
Price
2.63 CAD
Change
1.15%
52 weeks high
14.74
52 weeks low
1.70

In brief

FSD Pharma Inc. is a publicly-traded holding company, since May 2018.

FSD Pharma BioSciences, Inc., a wholly-owned subsidiary, is a specialty biotech pharmaceutical R&D company focused on developing over time multiple applications of its lead compound, ultramicronized-palmitoylethanolamide (“FSD201”), by down-regulating the cytokines to effectuate an anti-inflammatory response.

Snapshot

The company plans a Phase 2 study of FSD201 in more than 300 COVID-19 patients in October this year